Sensorion: new Chair of the Board of Directors

(CercleFinance.com) - This Monday, Sensorion announces the appointment of Scott Myers, a specialist in the biotech sector, for its Board of Directors.


The hearing-loss specialists indicated this morning that Myers will join the Board as an independent member to succeed Edwin Moses, who has decided to focus on other engagements, as Chair with immediate effect.

Sensorion points out that he will bring to the table close to 30 years' global experience in the pharmaceutical and medical technology sectors.

Scott Myers is also the Chair of the Board of Directors of Dynavax Technologies and Harpoon Therapeutics, two biopharmaceutical companies listed on the Nasdaq.

Copyright (c) 2021 CercleFinance.com. All rights reserved.